News Contact Us

Riverside confirms investment in SaaS provider Champion Healthcare

Author : Saif Ali Bepari | Published Date : 2019-06-08 

The Riverside Company, a leading private equity firm, has reportedly invested in Champion Healthcare Technologies, a SaaS provider that assists hospitals in managing surgical implants throughout their life cycle, from inventory storage, receipt and usage to post-surgical reporting and tracking.

Apparently, Champion is combining with HemaTerra Technologies, a recent Riverside investment that provides SaaS-based solutions to hospital-based and independent blood and plasma collection centers.

Sources familiar with the matter mentioned that the industry-leading solutions of Champion are used by some of the largest and most sophisticated health systems in the U.S. Through profound integration with vendors, system-wide visibility into analytics and implants and with the implant management software of Champion, it helps customers to improve patient safety, maintain compliance and reduce costs.

According to Loren Schlachet, a Riverside Managing Partner, the robust set of software solutions and near-perfect customer retention rates of Champion speak for themselves. Riverside will help to further expand its product development process and customer support efforts, he said.

The investment of Riverside in Champion will help HemaTerra to swiftly grow more meaningfully into the hospital market. This combination would create an industry-leading, medical specialty software company to help in connecting and coordinating various constituents in the supply chain, including tissue banks, blood banks, manufacturers, hospitals, volunteers, and donors, said Riverside Partner Joe Manning.

Seemingly, Champion is the latest example of Riverside’s commitment to investing in healthcare and software companies. Till date, the firm has invested in over 150 companies from these specific areas, having a team of worldwide experts focused on growing companies in these specializations.

For the uninitiated, Champion was founded in 2005 and provides complete implant management solutions to more than 500 health systems and hospitals. Its wide-ranging portfolio allows organizations to effectively manage and track implants throughout their life cycle to improve patient safety, minimize risk, and lower costs.

Source Credit: https://www.riversidecompany.com/en/News%20and%20Media/Press%20Releases/Champion%20News%20Release

About Author

Saif Ali Bepari

Saif Ali Bepari

A qualified Computer Science graduate, Saif Ali Bepari, armed with more of an inclination toward writing than coding, commenced his journey in the content industry as a freelancer. Currently penning down content for fractovia.org and a couple of other portals, Saif has also tinkered with creative writing, technical writing, blog writing, and copywriting. He can be contacted at- [email protected] | https://twitter.com/Saif_B17

Related News

Apellis Pharma reveals Phase 2 study data for APL-2 in AIHA patients

Published Date: 2019-06-17         Author: Saif Ali Bepari

Apellis Pharmaceuticals Inc. has reportedly announced the updated data from its key Phase 2 PLAUDIT study of APL-2 in patients with autoimmune hemolytic anemia (AIHA), including warm antibody autoimmune hemolytic anemia (wAIHA) and cold agglutinin disease (CAD). Sources close to the matter inform... Read More

Zensar collaborates with Cisco and NetApp on managed cloud services

Published Date: 2019-06-12         Author: Saif Ali Bepari

Zensar Technologies, a software and services company, has reportedly confirmed that it has partnered with Cisco and NetApp for the FlexPod converged infrastructure managed private cloud offering. Apparently, the service incorporates Cisco’s UCS compute or networking resources, NetApp storag... Read More

UK-based Sphere Fluidics secures $2.9M investment to expand operations

Published Date: 2019-06-11         Author: Saif Ali Bepari

Addition of new funds raised the total investment round to $4.8 million, with 24Haymarket Limited and Greenwood Way Capital as its leading investors   A research and development company based in the UK, Sphere Fluidics, which is currently commercializing single cell analysis system, has decl... Read More

© 2019 Fractovia. All Rights Reserved